LLY
Eli Lilly and Company (LLY) Lilly’s Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with psoriasis and obesity or overweight
Eli Lilly and Company (NYSE: LLY) FY 2026 Other Release
Eli Lilly and Company (LLY) TD Cowen’s 46th Annual Health Care Conference
Eli Lilly and Company (NYSE: LLY) FY 2026 Corporate Conference
Eli Lilly and Company (LLY) Lilly’s Retevmo (selpercatinib) delivers substantial event-free survival benefit as an adjuvant therapy in early-stage RET fusion-positive lung cancer
Eli Lilly and Company (NYSE: LLY) FY 2026 Other Release
Eli Lilly and Company (LLY) Sec Form 10K
Eli Lilly and Company (NYSE: LLY) Sec Form 10K
Eli Lilly and Company (LLY) to acquire Orna Therapeutics
Eli Lilly and Company (NYSE: LLY) on Monday said it signed an agreement to acquire Orna Therapeutics, Inc., a biotechnology…
Eli Lilly and Company (LLY) Lilly To Acquire Orna Therapeutics To Advance Cell Therapies
Eli Lilly and Company (NYSE: LLY) FY 2026 Other Release
Eli Lilly and Company (LLY) Q4 2025 Earnings Call
Eli Lilly and Company (NYSE: LLY) Q4 2025 Earnings Conference